http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-221649-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-824
filingDate 1998-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7a6a977fec8222b2528bcc80a48c22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7107d6fd7bd3b14b812470b946b5ce64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_461f3bb9d0ea2c98004f4f6f15bf5860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e230161c558ad4b97d958b317361142f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439987cd815c7db5ababd56f853a355c
publicationDate 2002-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-221649-B1
titleOfInvention Process for the preparation of N- (4-fluorophenyl) -N- (1-methyl-ethyl) -2- [5- (trifluoromethyl) -1,3,4-thiadiazol-2-yl] oxyacetamide \ t using an aromatic solvent
abstract The present invention relates to a process for N- (4-fluorophenyl) -N- (1-methylethyl) -2- [5- (trifluoromethyl) -1,3,4-thiadiazol-2-yl] oxy- to produce acetamide in an aprotic aromatic solvent. In step (a) of the process, 2- (methylsulfonyl) -5- (trifluoromethyl) -1,3,4-thiadiazole N- (4-fluorophenyl) -N- (1-methylethyl) Reacting with 2-hydroxyacetamide and aqueous alkali in the presence of a caprotic aromatic solvent to form an aqueous phase and a monoorganic phase; in step (b) the phases are acidified; in step (c) the phases are separated and in step (d) N- (4-fluorophenyl) -N- (1-methylethyl) -2- [5- (trifluoro) is recovered from the organic phase. (methyl) -1,3,4-thiadiazol-2-yl] oxyacetamide. The aprotic aromatic solvent used in the process is toluene, xylene, cumene or mesitylene. Aqueous alkali metal carbonate solution or aqueous alkali metal hydroxide solution is used as the aqueous alkaline agent. 2- (Methylsulfonyl) -5- (trifluoromethyl) -1,3,4-thiadiazole to N- (4-fluorophenyl) -N- (1-methylethyl) -2-hydroxyacetamide the relative molar ratio is preferably between about 1.5: 1 and about 1: 1.5. ŕ
priorityDate 1997-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12768404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421244281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426199373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410447160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13246791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67627387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420890145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411295332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12874685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413175265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449519999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13246790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426093024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5062481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55290227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450717807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90242192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411295330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13246789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426202872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431460864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10903198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421215711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12874671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421466870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421238819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15881135

Total number of triples: 71.